Abstract: Example embodiments provide a device that includes one or more of a first half-shell portion of an oval-shaped prism housing including one or more protrusions and one or more receiving slots, and a second half-shell portion of the oval-shaped prism housing including one or more additional protrusions and one or more additional receiving slots, and a number of cable splicer lanes configured to support corresponding cable splicers.

Abstract: A method of treating a condition comprising: administering a composition, wherein the composition comprises a Chelidonium majus extract and a tariquidar component, and wherein the condition is a cancer related to a gene selected from the group of genes including one or more of: STAG1A, STAG1B, FAM72C, ATF7-NPFF, SLX1B, MTRNR2L10, TMSB15A, Tb15, TbNB, TMSL8, TMSNB, TMSB15, TMSB15B, GP2, CSAG3, DNAJC25-GNG10, PIF1, BIVM, ERCC5, CSNK2A3, CT47A10, DRD2, BRINP2, PNPLA3, KLK13, and/or SERPINA6.

Abstract: A tactile signal seat belt sleeve has tactile signal producing elements arrayed along a sleeve that is adapted to fit over a seat belt for a vehicle, such as an aircraft. The elements may be arranged, for example, along the body-facing side of the belt. Each sleeve incorporates a signal-receiving element that allows for the activation of vibration-producing motors embedded in the fabric of the seat belt sleeve or belting. Vibration motors, such as piezoelectric devices, can be used to produce the tactile feedback. The haptic feedback assembly is connected to an interface unit that uses data from aircraft systems to sense, for example, the aircraft altitude and pitch, roll and yaw system. The interface unit generates signal to haptic devices to create appropriate vibrations patterns to the sleeve. The vibrations may be used to indicate directions of turn using output signals from various navigations systems.

Abstract: A medical fluid connector is described that includes a first fluid connector portion that can be connected to a second fluid connector portion. The first fluid connector portion includes a first locking member, a lumen and a septum for sealing the lumen. The second fluid connector portion includes a second locking member, a lumen and a hollow needle that is retained in and protrudes from the aperture at the end of the lumen. The variation in cross-sectional area of the fluid path through the fluid connector portion is less than 1 mm2 to reduce mixing effects. The use of such a connector for neurosurgical purposes is described.

Abstract: Fluid storage apparatus for medical use is described that includes a length of tubing having a first end and a second end. A first sealable connector portion is provided at the first end and a second sealable connector portion is provided at the second end. The volume of fluid that can be stored within the apparatus is known and an infusate or therapeutic agent is contained within the apparatus. In this manner, a known volume of therapeutic agent can be infused to a patient. The use in neurosurgical applications is described.

Abstract: Methods for powder coating that include applying a powder coating composition to a substrate via an electrostatic gun. The powder coating composition includes a mixture of two or more materials having different densities, such as a mixture of aerogel particles and fluoropolymer-containing particles. The electrostatic gun can have a high-voltage generator that generates a negative polarity voltage between about 0 KV and about 100 KV during application of the powder coating composition, and the electrostatic gun can have a round spray nozzle. Methods of making fuser members using such powder coating methods, fuser members prepared by such methods, and methods of preparing low gloss images using such fuser members.

Abstract: Methods for powder coating that include applying a powder coating composition to a substrate via an electrostatic gun. The powder coating composition includes a mixture of two or more materials having different densities, such as a mixture of aerogel particles and fluoropolymer-containing particles. The electrostatic gun can have a high-voltage generator that generates a negative polarity voltage between about 0 KV and about 100 KV during application of the powder coating composition, and the electrostatic gun can have a round spray nozzle. Methods of making fuser members using such powder coating methods, fuser members prepared by such methods, and methods of preparing low gloss images using such fuser members.

Abstract: There is described a method for producing a fuser member. A substrate is obtained and a fluoropolymer sleeve is positioned around an outer surface of the substrate. An elastomer is injected between the outer surface of the substrate and an inner surface of the sleeve to form a fuser member and demolded. The fuser member is conditioned at a first temperature of between about 30° C. below the melting point of the fluoropolymer and about 50° C. above the melting point of said fluoropolymer for about 1 to about 20 minutes. The fuser member is then optionally held at a second temperature of about 220° C. to about 260° C. for a period of about 4 hours to about 20 hours.

Abstract: The present invention discloses methods for inducing regression of a tumor in a subject by administering a pharmaceutical composition comprising a lentogenic strain of Newcastle disease virus (NDV). A preferred viral strain of NDV for inducing regression of a tumor in a subject is a clonal strain of NDV, the NDV HUJ. The methods of the present invention are particularly useful for inducing regression of tumors in patients unresponsive to conventional anti-cancer therapies.

Abstract: The present invention discloses lentogenic viral strains useful in the treatment of cancer. A preferred viral strain of Newcastle Disease Virus (NDV) is specifically characterized in terms of biological activities. The present invention further discloses treatment of cancer by application of a clonal NDV strain to tumors. Another feature of the invention is the use of at least one isolated viral glycoprotein or a subunit or analog thereof or of an isolated polynucleotide encoding the same for the treatment of cancer.

Abstract: The present invention discloses lentogenic viral strains useful in the treatment of cancer. A preferred viral strain of Newcastle Disease Virus (NDV) is specifically characterized in terms of biological activities. The present invention further discloses treatment of cancer by application of a clonal NDV strain to tumors. Another feature of the invention is the use of at least one isolated viral glycoprotein or a subunit or analog thereof or of an isolated polynucleotide encoding the same for the treatment of cancer.